TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...

The products are far from a proven sleep treatment.

Fallout 4 took a lot of design risks, including features that fundamentally changed how Bethesda designed open worlds.

FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

Ethics committees and funding agencies often receive protocols that involve either too many or too few animals to answer the specific research question being investigated. It is evident that a greater ...

After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...

This shift has accelerated sharply since 2023, driven by live-service models, Web3 experimentation, and growing regulatory ...

Physician groups betraying the public’s trust out of fear of government retaliation has permanent consequences,” writes a ...

Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...